IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.021
EU - Europa 12.217
AS - Asia 11.567
SA - Sud America 1.954
AF - Africa 312
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 21
Totale 51.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.675
CN - Cina 4.190
PL - Polonia 3.958
SG - Singapore 3.681
UA - Ucraina 2.111
BR - Brasile 1.608
DE - Germania 1.487
HK - Hong Kong 1.247
IT - Italia 1.215
VN - Vietnam 809
FI - Finlandia 792
GB - Regno Unito 647
FR - Francia 553
RU - Federazione Russa 415
IN - India 403
TR - Turchia 403
IE - Irlanda 373
BD - Bangladesh 170
CA - Canada 162
SE - Svezia 118
AR - Argentina 111
ZA - Sudafrica 111
MX - Messico 105
CZ - Repubblica Ceca 102
NL - Olanda 101
ES - Italia 100
JP - Giappone 97
ID - Indonesia 95
IQ - Iraq 76
AU - Australia 67
EC - Ecuador 62
PK - Pakistan 52
MA - Marocco 47
AT - Austria 43
CO - Colombia 43
IR - Iran 42
BE - Belgio 41
VE - Venezuela 40
SA - Arabia Saudita 37
CL - Cile 32
KE - Kenya 30
NG - Nigeria 26
UZ - Uzbekistan 26
LT - Lituania 22
PE - Perù 22
CH - Svizzera 21
AZ - Azerbaigian 20
JM - Giamaica 20
MU - Mauritius 20
EU - Europa 19
IL - Israele 19
JO - Giordania 19
AE - Emirati Arabi Uniti 17
MY - Malesia 17
PH - Filippine 17
PY - Paraguay 17
EG - Egitto 16
KR - Corea 16
TN - Tunisia 16
TH - Thailandia 15
DZ - Algeria 14
KZ - Kazakistan 14
PA - Panama 13
RO - Romania 13
BG - Bulgaria 12
NO - Norvegia 11
NP - Nepal 10
ET - Etiopia 9
HU - Ungheria 9
KG - Kirghizistan 9
TW - Taiwan 9
UY - Uruguay 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
GE - Georgia 8
GR - Grecia 8
LK - Sri Lanka 8
LV - Lettonia 8
CU - Cuba 7
DK - Danimarca 7
LB - Libano 7
OM - Oman 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
HR - Croazia 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
AL - Albania 5
CR - Costa Rica 5
HN - Honduras 5
BH - Bahrain 4
BY - Bielorussia 4
EE - Estonia 4
RS - Serbia 4
SV - El Salvador 4
AM - Armenia 3
AO - Angola 3
CI - Costa d'Avorio 3
CY - Cipro 3
Totale 51.110
Salva come PNG Salva come JPEG
Città #
Warsaw 3.948
Fairfield 3.027
Ashburn 2.297
Woodbridge 2.187
Singapore 1.968
Jacksonville 1.581
Houston 1.515
Hong Kong 1.234
Ann Arbor 1.179
Cambridge 1.173
Seattle 1.102
Wilmington 1.062
San Jose 928
Beijing 905
Chandler 798
The Dalles 732
Princeton 669
Nanjing 581
New York 501
Helsinki 438
Los Angeles 432
Brescia 385
Dublin 369
Dearborn 337
Dallas 332
Istanbul 305
Lauterbourg 303
Ho Chi Minh City 224
Munich 222
Dong Ket 181
Nanchang 180
Council Bluffs 174
São Paulo 166
San Francisco 163
Buffalo 162
Moscow 160
Shenyang 151
Des Moines 150
Milan 149
Hebei 144
Jinan 144
Changsha 139
Shanghai 136
San Diego 135
Hanoi 126
Chicago 118
Santa Clara 110
Tianjin 106
Orem 105
Lancaster 104
Jiaxing 101
London 99
Redondo Beach 97
Tokyo 88
Boardman 78
Kunming 73
Brooklyn 69
Phoenix 69
Turku 69
Jakarta 66
Hangzhou 65
Brno 64
Chennai 63
San Mateo 61
Guangzhou 59
Johannesburg 57
Madrid 55
Boston 53
Verona 53
Porto Alegre 51
Rome 50
Haikou 48
Toronto 48
Rio de Janeiro 46
Amsterdam 45
Zhengzhou 45
Montreal 44
Ningbo 44
Augusta 43
Stockholm 43
Lanzhou 42
Nuremberg 42
Atlanta 40
Denver 39
Manchester 38
Belo Horizonte 36
Brussels 35
Kocaeli 35
Poplar 34
Leawood 33
Washington 33
Mexico City 32
Charlotte 31
Curitiba 29
Fuzhou 29
Dhaka 28
Haiphong 28
Paris 28
Taizhou 28
Frankfurt am Main 27
Totale 36.250
Salva come PNG Salva come JPEG
Nome #
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 372
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 366
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 346
The nanostructured secretome 346
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 343
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 341
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 317
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 311
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 302
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 301
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 299
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 298
Claudin3 is localized outside the tight junctions in human carcinomas 290
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 287
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 287
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 282
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 281
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 279
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 279
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 278
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 276
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 274
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 272
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 271
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 271
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 270
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 267
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 267
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 266
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 264
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 254
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 252
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 248
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 246
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 245
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 238
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 234
Zebrafish disease models in hematology: Highlights on biological and translational impact 233
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 226
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 224
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 224
Long pentraxin-3 follows and modulates bladder cancer progression 218
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 215
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 212
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 212
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 212
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 211
Anti-angiogenic activity of the purine analog 6-thioguanine. 209
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 207
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 206
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 206
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 206
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 204
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 204
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 204
The zebrafish/tumor xenograft angiogenesis assay. 203
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 203
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 202
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 198
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 197
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 196
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 193
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 193
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 191
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 190
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 189
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 189
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 188
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 188
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 187
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 187
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 187
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 185
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 185
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 184
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 184
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 183
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 181
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 181
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 181
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 181
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 180
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 178
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 176
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 175
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 175
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 175
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 175
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 174
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 174
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 173
Beta-Galactosylceramidase deficiency: neurovascular implications 173
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 172
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 170
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 169
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 169
Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications 167
Circulating microRNAs and Their Role in Multiple Myeloma 167
Long pentraxin 3: A novel multifaceted player in cancer 167
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 166
Totale 22.654
Salva come PNG Salva come JPEG
Categoria #
all - tutte 216.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.609 0 0 0 0 0 0 0 0 0 527 702 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20256.143 86 57 40 861 652 574 516 250 708 468 1.139 792
2025/202612.373 1.327 1.675 1.078 1.838 1.441 883 2.044 444 792 851 0 0
Totale 51.915